RENATO DELACRUZ: Open Payments
NPI 1174523641 · SAINT CLAIRSVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,429 in 152 payments from 28 companies in 2025. Trend: 2023 $2,884 · 2024 $4,430 · 2025 $3,429
Food & beverage: $3,403Education: $26
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $561 |
| AstraZeneca Pharmaceuticals LP | 19 | $443 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $342 |
| Corcept Therapeutics | 14 | $327 |
| Abbott Laboratories | 8 | $258 |
| Novo Nordisk Inc | 15 | $252 |
| PFIZER INC. | 12 | $201 |
| Otsuka America Pharmaceutical, Inc. | 7 | $199 |
| Exact Sciences Corporation | 5 | $113 |
| Lundbeck LLC | 5 | $105 |
Products named: Kerendia, Korlym, REXULTI, QULIPTA, AIRSUPRA, FREESTYLE LIBRE 3, Ozempic, VRAYLAR.
Industry payments across OH — which companies pay providers there.
